Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia

dc.contributor.authorAyyildiz, O
dc.contributor.authorIsikdogan, A
dc.contributor.authorBolaman, Z
dc.contributor.authorMuftuoglu, E
dc.date.accessioned2024-04-24T17:34:01Z
dc.date.available2024-04-24T17:34:01Z
dc.date.issued2004
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage2056en_US
dc.identifier.issn0379-5284
dc.identifier.issue12en_US
dc.identifier.pmid15711709
dc.identifier.scopus2-s2.0-13844297855
dc.identifier.scopusqualityQ2
dc.identifier.startpage2054en_US
dc.identifier.urihttps://hdl.handle.net/11468/20925
dc.identifier.volume25en_US
dc.identifier.wosWOS:000226661000068
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSaudi Med Jen_US
dc.relation.ispartofSaudi Medical Journal
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleFludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemiaen_US
dc.titleFludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia
dc.typeEditorialen_US

Dosyalar